Project Description

  • Polycythemia Vera, treatment strategies.
  • Ruxolitinib clinical program on PV (RESPONSE phase III trial update)
  • Current treatment strategies for PV and JAK inhibitors place in therapy

Ruben Mesa, MD

Consultant Hematologist Professor and Chair Hematology and Medical Oncology- Mayo Clinic. Arizona, USA

Back to sessions Next session